SUDHISHA JALA: Open Payments
NPI 1659895373 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,362 in 50 payments from 18 companies in 2025. Trend: 2023 $725 · 2024 $1,195 · 2025 $1,362
Food & beverage: $1,263Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $389 |
| Ardelyx, Inc. | 5 | $151 |
| Madrigal Pharmaceuticals | 5 | $117 |
| Janssen Biotech, Inc. | 1 | $99 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $97 |
| Amgen Inc. | 1 | $91 |
| GENZYME CORPORATION | 2 | $57 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $55 |
| VIVUS LLC | 2 | $51 |
| QOL Medical, LLC | 2 | $48 |
Products named: SKYRIZI, IBSRELA, REZDIFFRA, TREMFYA, RINVOQ, KRYSTEXXA, LINZESS, DUPIXENT.
Industry payments across GA — which companies pay providers there.
